Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00004497 | Phase III Randomized Study of UT-15 in Patients With Primary Pulmonary Hypertension | PHASE3 | COMPLETED | - | — | — | Oct 1, 1998 | Sep 1, 2000 | Mar 25, 2015 | 7 | United States |
| Name | Type | Description |
|---|---|---|
| UT-15 | DRUG | - |
PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- Diagnosis of moderate to severe precapillary pulmonary hypertension (New York Heart Association class III/IV) unresponsive to attempted use of chronic oral vasodilators for at least 1 month Cardiac catheterization at baseline: Pulmonary artery ...